• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态传播建模:ISPOR-SMDM 建模良好实践工作组第 5 工作组报告。

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.

机构信息

Oxford Outcomes, Oxford, United Kingdom (RP)

Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada (DF)

出版信息

Med Decis Making. 2012 Sep-Oct;32(5):712-21. doi: 10.1177/0272989X12454578.

DOI:10.1177/0272989X12454578
PMID:22990086
Abstract

The transmissible nature of communicable diseases is what sets them apart from other diseases modeled by health economists. The probability of a susceptible individual becoming infected at any one point in time (the force of infection) is related to the number of infectious individuals in the population, will change over time, and will feed back into the future force of infection. These nonlinear interactions produce transmission dynamics that require specific consideration when modeling an intervention that has an impact on the transmission of a pathogen. Best practices for designing and building these models are set out in this paper.

摘要

传染病的传染性使其有别于健康经济学家所建模的其他疾病。在任何一个时间点(感染率),易感个体被感染的概率与人群中感染个体的数量有关,它会随时间变化,并会反馈到未来的感染率中。这些非线性相互作用产生了传播动态,在对影响病原体传播的干预措施进行建模时需要特别考虑。本文阐述了设计和构建这些模型的最佳实践。

相似文献

1
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.动态传播建模:ISPOR-SMDM 建模良好实践工作组第 5 工作组报告。
Med Decis Making. 2012 Sep-Oct;32(5):712-21. doi: 10.1177/0272989X12454578.
2
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.动态传播建模:ISPOR-SMDM 建模良好实践工作组的报告——5.
Value Health. 2012 Sep-Oct;15(6):828-34. doi: 10.1016/j.jval.2012.06.011.
3
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.建立良好研究实践模型——概述:ISPOR-SMDM 建立良好研究实践工作组 1 的报告。
Med Decis Making. 2012 Sep-Oct;32(5):667-77. doi: 10.1177/0272989X12454577.
4
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.模型化良好的研究实践概述:ISPOR-SMDM 模型化良好的研究实践工作组的报告——1.
Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012.
5
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.模型参数估计和不确定性分析:ISPOR-SMDM 建模良好实践工作组第 6 工作组的报告。
Med Decis Making. 2012 Sep-Oct;32(5):722-32. doi: 10.1177/0272989X12458348.
6
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.状态转移建模:ISPOR-SMDM 建模良好实践工作组报告-3。
Med Decis Making. 2012 Sep-Oct;32(5):690-700. doi: 10.1177/0272989X12455463.
7
Selecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force.为医疗服务研究选择动态模拟建模方法——第2部分:ISPOR动态模拟建模新兴良好实践特别工作组报告
Value Health. 2015 Mar;18(2):147-60. doi: 10.1016/j.jval.2015.01.006.
8
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.概念化模型:ISPOR-SMDM 建模良好研究实践工作组 2 的报告。
Med Decis Making. 2012 Sep-Oct;32(5):678-89. doi: 10.1177/0272989X12454941.
9
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4.使用离散事件模拟建模:ISPOR-SMDM 建模良好实践工作组的报告-4。
Med Decis Making. 2012 Sep-Oct;32(5):701-11. doi: 10.1177/0272989X12455462.
10
Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force.改善卫生技术评估中的模型验证:对ISPOR-SMDM建模良好研究实践工作组指南的评论
Value Health. 2013 Sep-Oct;16(6):1106-7. doi: 10.1016/j.jval.2013.06.015.

引用本文的文献

1
Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.登革热疫苗TAK - 003的接种策略、公共卫生影响及成本效益:泰国的一项建模案例研究
PLoS Med. 2025 Jun 17;22(6):e1004631. doi: 10.1371/journal.pmed.1004631. eCollection 2025 Jun.
2
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain.对西班牙老年人群流感疫苗经济评估中不确定性的批判性评估。
BMC Infect Dis. 2025 Feb 1;25(1):152. doi: 10.1186/s12879-025-10442-3.
3
Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions.
传染病干预措施所避免和可避免结果分析的因果估计量
Epidemiology. 2025 May 1;36(3):363-373. doi: 10.1097/EDE.0000000000001839. Epub 2025 Jan 24.
4
The role of economic evaluation in modelling public health and social measures for pandemic policy: a systematic review.经济评估在为大流行政策制定公共卫生和社会措施模型中的作用:一项系统综述。
Cost Eff Resour Alloc. 2024 Nov 1;22(1):77. doi: 10.1186/s12962-024-00585-6.
5
Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review.2019冠状病毒病传染病模型纳入了健康的社会决定因素吗?一项系统综述。
Public Health Rev. 2024 Oct 10;45:1607057. doi: 10.3389/phrs.2024.1607057. eCollection 2024.
6
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.基于模型的 COVID-19 药物治疗在大流行情况下的经济评估的经验教训:系统评价的结果。
Pharmacoeconomics. 2024 Jun;42(6):633-647. doi: 10.1007/s40273-024-01375-x. Epub 2024 May 10.
7
Examining the Influence of Imbalanced Social Contact Matrices in Epidemic Models.考察不均衡社会接触矩阵在流行病模型中的影响。
Am J Epidemiol. 2024 Feb 5;193(2):339-347. doi: 10.1093/aje/kwad185.
8
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making.疫苗评估的全部价值(FVVA):评估和沟通疫苗投资和引入决策价值的框架。
BMC Med. 2023 Jul 4;21(1):229. doi: 10.1186/s12916-023-02929-0.
9
Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden.在丹麦、挪威和瑞典,与标准剂量和高剂量疫苗相比,使用含MF59佐剂的四价流感疫苗对老年人进行疫苗接种的成本效益分析。
Vaccines (Basel). 2023 Mar 29;11(4):753. doi: 10.3390/vaccines11040753.
10
Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review.新冠疫情背景下接触者追踪干预措施的效果比较:系统评价。
Eur J Epidemiol. 2023 Mar;38(3):243-266. doi: 10.1007/s10654-023-00963-z. Epub 2023 Feb 16.